Acute Myeloid Leukemia
Showing NaN - NaN of 56
Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Azacitidine
- +2 more
-
Baltimore, Maryland
- +2 more
Feb 25, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)
Recruiting
- Acute Myeloid Leukemia
- Calaspargase pegol-mknl
-
Baltimore, MarylandGreenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021
Oncology, Acute Myeloid Leukemia Trial in United States (Open Label LAM-003)
Completed
- Oncology
- Acute Myeloid Leukemia
- Open Label LAM-003
-
New Haven, Connecticut
- +5 more
Dec 17, 2021
Acute Myeloid Leukemia Trial in United States (AMV564, AMV564 in combination with pembrolizumab)
Completed
- Acute Myeloid Leukemia
- AMV564
- AMV564 in combination with pembrolizumab
-
San Francisco, California
- +9 more
Oct 11, 2021
Advanced Solid Tumors, Acute Myeloid Leukemia Trial in United States (Gilteritinib)
Completed
- Advanced Solid Tumors
- Acute Myeloid Leukemia
-
Phoenix, Arizona
- +6 more
Sep 16, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia-2, High Risk Myelodysplastic Syndrome Trial in New Haven, Baltimore,
Completed
- Acute Myeloid Leukemia
- +3 more
- Cytarabine
- +6 more
-
New Haven, Connecticut
- +2 more
Oct 10, 2020
Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)
Acute Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Leukemia, Bilineage, Acute Trial in Baltimore (Ex vivo expansion of cord
Terminated
- Acute Myeloid Leukemia
- +3 more
- Ex vivo expansion of cord blood
-
Baltimore, MarylandJohns Hopkins Hospital
Feb 14, 2020
Acute Myeloid Leukemia Trial in Worldwide (Compound AC220)
Completed
- Acute Myeloid Leukemia
- Compound AC220
-
San Francisco, California
- +84 more
Dec 3, 2019
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York
Completed
- Acute Myeloid Leukemia
- +7 more
-
Baltimore, Maryland
- +2 more
Oct 17, 2019
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Acute Myeloid Leukemia Trial in Germany, Italy, United States (Gilteritinib, Voriconazole, Midazolam)
Acute Myeloid Leukemia, Essential Thrombocythemia Trial in United States (LY573636-sodium)
Completed
- Acute Myeloid Leukemia
- Essential Thrombocythemia
-
Los Angeles, California
- +4 more
Dec 16, 2018
Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Canada, United States (procedure, drug, other)
Completed
- Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +5 more
-
Birmingham, Alabama
- +446 more
Nov 28, 2018
Acute Myeloid Leukemia Trial in Baltimore (Cytarabine consolidation, Allogeneic transplant)
Terminated
- Acute Myeloid Leukemia
- Cytarabine consolidation
- Allogeneic transplant
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 17, 2018
Acute Myeloid Leukemia Trial in Baltimore (Erwinase)
Completed
- Acute Myeloid Leukemia
-
Baltimore, MarylandUniversity of Maryland Greenebaum Cancer Center
Mar 8, 2018
Acute Myeloid Leukemia Trial in United States (Voreloxin injection and cytarabine)
Completed
- Acute Myeloid Leukemia
- Voreloxin injection and cytarabine
-
Denver, Colorado
- +8 more
Dec 11, 2017